|
|
 Sustiva Information - August 8, 2008
| Treating HIV and AIDS patients earlier using early antiretroviral therapy might be effective, a U.S. researcher told the International AIDS Society on Monday. Scott Hammer a Columbia University researcher and a member of the International AIDS Society-USA Panel indicated that new data he had analyzed in the field over the last two years suggests initiating therapy before CD4 cell count declines to less than 350/L | | Anti-retroviral drug therapy has slashed AIDS death rates to match those of uninfected people in the first five years after the virus attacks the body, new British research has found. Since the introduction of anti-retroviral drugs such as Bristol-Myers Squibb Co's. Sustiva in 1996, the five-year, post-diagnosis survival for those infected sexually is now about equal to that of the general population | | The Food and Drug Administration (FDA) has approved the sale of Atripla, a once-a-day pills that contains three FDA-approved drugs that can be taken in a single dose. The "cocktail" was approved for sale by the FDA on Wednesday and will be made available within seven working days. The new drug is expected to be a big help to HIV-positive patients | | Doctors and State of New York Health Officials have been on the outlook for a man who is carrying a deadly strain of the HIV virus that is resistant to practically all available treatments for the virus. Dr. Gary Blick, a private-practice physician in Norwalk, Conn has the patient who is responsible for spreading the strain through unprotected anonomoyus anal sex that the man had with others in a sex club in New York City in 2004 | |
|
|